Warfarin therapy not warranted for secondary prevention of CVD

MOspace/Manakin Repository

Breadcrumbs Navigation

Warfarin therapy not warranted for secondary prevention of CVD

Please use this identifier to cite or link to this item: http://hdl.handle.net/10355/7655

[+] show full item record


Title: Warfarin therapy not warranted for secondary prevention of CVD
Author: Wong, Long; Criswell, Dan
Keywords: thrombotic occlusion
aspirin therapy
Date: 2009-12
Publisher: Family Physicians Inquiries Network
Citation: Evidence Based Practice 12(12): 01-02.
Abstract: No data are available to support the addition or substitution of warfarin after failure of antiplatelet agents for secondary prevention of ischemic stroke. Further, warfarin may be no better than placebo at reducing the risk of noncardioembolic stroke. (Strength of recommendation [SOR] B, based on heterogeneous meta-analyses.)
URI: http://hdl.handle.net/10355/7655

This item appears in the following Collection(s)

[+] show full item record